Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy
Background Recessive mutations in the thymidinekinase 2 (TK2) gene cause a rare mitochondrial myopathy, frequently with severe respiratory involvement. Deoxynucleoside therapy is currently under investigation.Research question What is the impact of nucleosides in respiratory function in patients wit...
Saved in:
| Main Authors: | Cristina Domínguez-González, Ana Hernandez-Voth, Javier Sayas Catalan, Marta Corral Blanco, Alba Castaño Mendez, Miguel Angel Martin, Carlos De Fuenmayor Fernandez de la Hoz, Victoria Villena Garrido |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000774.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial Myopathy Associated with Thymidine Kinase-2 Enzyme Deficiency in a Child of the First Year of Life: Case Report
by: Svetlana A. Ragimova, et al.
Published: (2025-05-01) -
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
by: Caterina Garone, et al.
Published: (2014-06-01) -
New Benzimidazole 3′-Deoxynucleosides: Synthesis and Antiherpes Virus Properties
by: Aleksandra O. Arnautova, et al.
Published: (2025-06-01) -
Optimized Method for the Synthesis of Alkyne-Modified 2′-Deoxynucleoside Triphosphates
by: Viktoriya E. Kuznetsova, et al.
Published: (2024-10-01) -
Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC
by: Chia-Jung Lee, et al.
Published: (2025-06-01)